Reset filters
  • 5 February 2008

CROI: Risk of treatment interruption persists after restarting HAART

Read the article
  • 9 January 2008

High prevalence of asymptomatic heart disease in HIV-positive patients

Read the article
  • 17 October 2007

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Read the article
  • 19 September 2007

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

Read the article
  • 24 July 2007

IAS: ART interruption particularly unsafe for HIV-positive patients coinfected with hepatitis B or C

Read the article
  • 21 June 2007

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

Read the article
  • 20 June 2007

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Read the article
  • 4 March 2007

CROI: SMART substudy finds people on treatment less likely to transmit HIV, and may take fewer risks

Read the article
  • 27 February 2007

CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.